The role of bevacizumab as first-line therapy for colon cancer. [electronic resource]
Producer: 20060303Description: S43-7 p. digitalISSN:- 0093-7754
- Adenocarcinoma -- drug therapy
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab
- Camptothecin -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Fluorouracil -- administration & dosage
- Humans
- Irinotecan
- Leucovorin -- administration & dosage
- Randomized Controlled Trials as Topic
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.